Literature DB >> 24365649

The association between vasomotor symptoms and depression during perimenopause: a systematic review.

Roisin Worsley1, Robin Bell2, Jayashri Kulkarni3, Susan R Davis2.   

Abstract

There is a high incidence of depression in women presenting to menopause clinics. The aim of this review was to determine if there is an association between depressive symptoms or major depressive disorder (MDD) and vasomotor symptoms (VMS). A systematic review of the literature was conducted according to PRISMA guidelines. 33 relevant publications were found, 12 from three large studies. Overall, we found that there is a bidirectional association between VMS and depressive symptoms. This has been established in well-conducted, large observational studies. There does not appear to be a relationship between VMS and MDD. However, studies examining VMS and MDD were prone to bias making it difficult to draw any conclusions.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Depression; Hot flushes; Major depressive disorder; Perimenopause; Vasomotor

Mesh:

Year:  2013        PMID: 24365649     DOI: 10.1016/j.maturitas.2013.11.007

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  19 in total

1.  The role of sleep difficulties in the vasomotor menopausal symptoms and depressed mood relationships: an international pooled analysis of eight studies in the InterLACE consortium.

Authors:  Hsin-Fang Chung; Nirmala Pandeya; Annette J Dobson; Diana Kuh; Eric J Brunner; Sybil L Crawford; Nancy E Avis; Ellen B Gold; Ellen S Mitchell; Nancy F Woods; Joyce T Bromberger; Rebecca C Thurston; Hadine Joffe; Toyoko Yoshizawa; Debra Anderson; Gita D Mishra
Journal:  Psychol Med       Date:  2018-02-12       Impact factor: 7.723

2.  Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the Midlife Women's Health Study.

Authors:  Lisa Gallicchio; Susan R Miller; Judith Kiefer; Teresa Greene; Howard A Zacur; Jodi A Flaws
Journal:  Menopause       Date:  2015-10       Impact factor: 2.953

3.  Impact of Estradiol Variability and Progesterone on Mood in Perimenopausal Women With Depressive Symptoms.

Authors:  Hadine Joffe; Anouk de Wit; Jamie Coborn; Sybil Crawford; Marlene Freeman; Aleta Wiley; Geena Athappilly; Semmie Kim; Kathryn A Sullivan; Lee S Cohen; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

4.  Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study.

Authors:  Camilla Callegari; Marta Ielmini; Ivano Caselli; Giulia Lucca; Celeste Isella; Marcello Diurni; Fabiana Pettenon; Nicola Poloni
Journal:  Psychopharmacol Bull       Date:  2019-02-15

5.  Anterior Insula Activation During Cardiac Interoception Relates to Depressive Symptom Severity in HIV-Positive and HIV-Negative Postmenopausal Women.

Authors:  Roger C McIntosh; Judith D Lobo; Michael Reed; Jennifer C Britton
Journal:  Psychosom Med       Date:  2022-09-06       Impact factor: 3.864

6.  Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women.

Authors:  Hadine Joffe; Sybil L Crawford; Marlene P Freeman; David P White; Matt T Bianchi; Semmie Kim; Nicole Economou; Julie Camuso; Janet E Hall; Lee S Cohen
Journal:  J Clin Endocrinol Metab       Date:  2016-09-28       Impact factor: 5.958

7.  Vascular dysfunction across the stages of the menopausal transition is associated with menopausal symptoms and quality of life.

Authors:  Kerry L Hildreth; Cemal Ozemek; Wendy M Kohrt; Patrick J Blatchford; Kerrie L Moreau
Journal:  Menopause       Date:  2018-09       Impact factor: 2.953

8.  Relationship between Type-D personality, physical activity behaviour and climacteric symptoms.

Authors:  Erika Borkoles; Nick Reynolds; Chantal F Ski; Lilly Stojanovska; David R Thompson; Remco C J Polman
Journal:  BMC Womens Health       Date:  2015-02-22       Impact factor: 2.809

9.  Negative affect symptoms, anxiety sensitivity, and vasomotor symptoms during perimenopause.

Authors:  Marianna de B Jaeger; Camila S Miná; Sofia Alves; Gabriela J Schuh; Maria C Wender; Gisele G Manfro
Journal:  Braz J Psychiatry       Date:  2020-10-09       Impact factor: 2.697

Review 10.  Management of endometrial modifications in perimenopausal women.

Authors:  Renata Nicula; Nicolae Costin
Journal:  Clujul Med       Date:  2015-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.